IN2013MU03862A - - Google Patents

Info

Publication number
IN2013MU03862A
IN2013MU03862A IN3862MU2013A IN2013MU03862A IN 2013MU03862 A IN2013MU03862 A IN 2013MU03862A IN 3862MU2013 A IN3862MU2013 A IN 3862MU2013A IN 2013MU03862 A IN2013MU03862 A IN 2013MU03862A
Authority
IN
India
Prior art keywords
ertapenem
solvates
hydrates
formula
preparation
Prior art date
Application number
Other languages
English (en)
Inventor
Trushal J Patel
Hitesh Mathukiya
Shilpi Tomar
Sekhar Reddy Brc
Rushikesh U Roy
Krishnarao Tukaram Shirsath
Yogendra Kumar Chauhan
Original Assignee
Unimark Remedies Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unimark Remedies Ltd filed Critical Unimark Remedies Ltd
Priority to PCT/IB2014/066744 priority Critical patent/WO2015087245A1/en
Priority to IN3862MU2013 priority patent/IN2013MU03862A/en
Publication of IN2013MU03862A publication Critical patent/IN2013MU03862A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IN3862MU2013 2013-12-11 2014-12-10 IN2013MU03862A (xx)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PCT/IB2014/066744 WO2015087245A1 (en) 2013-12-11 2014-12-10 Process for preparation of ertapenem and salts thereof
IN3862MU2013 IN2013MU03862A (xx) 2013-12-11 2014-12-10

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN3862MU2013 IN2013MU03862A (xx) 2013-12-11 2014-12-10

Publications (1)

Publication Number Publication Date
IN2013MU03862A true IN2013MU03862A (xx) 2015-07-31

Family

ID=52350167

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3862MU2013 IN2013MU03862A (xx) 2013-12-11 2014-12-10

Country Status (2)

Country Link
IN (1) IN2013MU03862A (xx)
WO (1) WO2015087245A1 (xx)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114105988A (zh) * 2022-01-24 2022-03-01 深圳市海滨制药有限公司 一种厄他培南钠的合成方法

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106749258B (zh) * 2015-11-24 2020-08-21 重庆圣华曦药业股份有限公司 一种厄他培南钠的纯化方法
CN106279175A (zh) * 2016-08-12 2017-01-04 上海龙翔生物医药开发有限公司 一种厄他培南单钠盐的制备方法
US10434089B2 (en) 2017-01-25 2019-10-08 The Johns Hopkins University Avibactam and carbapenems antibacterial agents
CN110423237B (zh) * 2019-09-10 2021-12-31 石药集团中诺药业（石家庄）有限公司 一种厄他培南钠的精制方法
CN113880839A (zh) * 2021-11-01 2022-01-04 石药集团中诺药业（石家庄）有限公司 一种厄他培南钠粗品的合成新方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9202298D0 (en) 1992-02-04 1992-03-18 Ici Plc Antibiotic compounds
US5872250A (en) 1997-07-30 1999-02-16 Merck & Co., Inc. Process for synthesizing carbapenem antibiotics
US6504027B1 (en) 1998-03-02 2003-01-07 Merck & Co., Inc. Decarboxylation process for synthesizing carbapenem antibiotics
WO2003027067A2 (en) 2001-09-26 2003-04-03 Merck & Co., Inc. Process for making carbapenem compounds
USRE40794E1 (en) * 2001-09-26 2009-06-23 Merck & Co., Inc. Crystalline forms of carbapenem antibiotics and methods of preparation
US8293894B2 (en) 2006-11-20 2012-10-23 Orchid Chemicals & Pharmaceuticals Limited Process for the preparation of carbapenem antibiotic
CN101376633B (zh) 2007-08-28 2011-08-10 上海医药工业研究院 碳青霉烯类青霉素厄他培南的中间体及其制备方法和应用
CN101376642B (zh) 2007-08-28 2010-12-01 上海医药工业研究院 碳青霉烯类青霉素厄他培南的中间体及其制备方法和应用
CN101376643B (zh) 2007-08-28 2011-04-06 上海医药工业研究院 一种碳青霉烯类青霉素厄他培南的中间体的制备方法
CN101376641B (zh) 2007-08-28 2010-12-08 上海医药工业研究院 碳青霉烯类青霉素厄他培南的中间体及其制备方法和应用
CN101376645B (zh) 2007-08-28 2010-12-22 上海医药工业研究院 碳青霉烯类青霉素厄他培南的中间体及其制备方法和应用
EP2505191A1 (en) 2008-06-11 2012-10-03 Ranbaxy Laboratories Limited Lyophilized Carbapenem antibiotic composition
US8729260B2 (en) * 2010-05-19 2014-05-20 Savior Lifetec Corporation Process for the preparation of carbapenem using cabapenem intermediates and recovery of cabapenem
CN102558182B (zh) 2010-12-31 2015-02-11 石药集团中奇制药技术（石家庄）有限公司 一种厄他培南钠晶型及其制备方法
CN102363617B (zh) 2011-11-09 2013-09-18 上海希迈医药科技有限公司 一种厄他培南单钠盐结晶体及其制备方法

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114105988A (zh) * 2022-01-24 2022-03-01 深圳市海滨制药有限公司 一种厄他培南钠的合成方法

Also Published As

Publication number Publication date
WO2015087245A1 (en) 2015-06-18

Similar Documents

Publication Publication Date Title
PH12019501321A1 (en) Methods of treating or preventing cholesterol related disorders
MX2019011926A (es) Metodos utiles en la sintesis de analogos de halicondrina b.
IN2015DN01156A (xx)
PH12015502031B1 (en) Tetrahydropyrrolothiazine compounds
PH12016501192A1 (en) Tetrahydropyridopyrazines modulators of gpr6
MX2020001756A (es) Compuestos deuterados del inhibidor vmat y el uso de dichos compuestos.
MA40171A (fr) Dérivés d'azamophinan et leur utilisation
PH12015501588A1 (en) Compounds and methods for treating bacterial infections
IN2013MU03862A (xx)
PH12016500347A1 (en) Triazolopyridine compounds, compositions and methods of use thereof
IN2013MU01985A (xx)
IN2013MU00665A (xx)
MX2016000487A (es) Piridina-2-carboxamidas como nematicidas.
IN2013MU04056A (xx)
IN2013MU03565A (xx)
GB2564185A (en) Process for the preparation of derivatives of benzodioxole
PH12015502703A1 (en) Pharmaceutical compositions
MX2016005511A (es) Intermediarios y metodos para sintetizar derivados de calicheamicina.
MX2015011881A (es) Proceso para la preparacion de 3,7-dimetilnonan-1-ol.
IN2013MU02010A (xx)
MX2016002186A (es) Proceso para preparar dronedarona y sales de la misma.
MX2017005669A (es) Derivados de hidroxido de bencilo, preparacion de los mismos y uso terapeutico de los mismos.
MX2018002193A (es) Metodo de uso de quinoxalinilo-piperazinamida.
UA91886U (uk) 1-трет-бутокси-3-(2,2,6,6-тетраметил-4-гідроксипіперидино)-2-пропанол
IN2013DE03592A (xx)